St. Luke's Cancer Centre, Royal Surrey County Hospital, Surrey, UK.
Radiother Oncol. 2009 Oct;93(1):125-30. doi: 10.1016/j.radonc.2009.06.010. Epub 2009 Jul 13.
Doses in conventional radiotherapy for extremity soft tissue sarcoma (STS) potentially exceed normal tissue tolerances. This study compares 3D-conformal radiotherapy (3D-CRT) with intensity-modulated radiotherapy (IMRT) in optimising target volume coverage and minimising integral dose to organs-at-risk (OAR).
Ten patients undergoing post-operative radiotherapy for extremity STS were assessed. PTV(1) was defined as tumour bed plus 5cm superiorly/inferiorly and 3cm circumferentially, PTV(2) was defined as 2cm isotropically. OAR were defined as whole femur, neurovascular bundle, tissue corridor and normal tissue outside PTV(1). For each patient 2-phase 3D-CRT was compared to 2/3 field (2/3f) and 4/5 field (4/5f) IMRT with simultaneous integrated boost (SIB). The primary planning objective was to minimise femur and skin corridor dose. Volumetric analysis and conformity and heterogeneity indices were used for plan comparison.
A planning protocol containing dose/volume constraints for target and OAR was defined. 4/5f IMRT showed greatest conformity and homogeneity. IMRT resulted in significantly lower femur V45 using 2/3f (p=0.01) and 4/5f (p=0.0009) than 3D-CRT. 4/5f IMRT resulted in significantly lower normal tissue V55 (p=0.004) and maximum dose (p=0.04) than 3D-CRT.
A reproducible set of planning guidelines and dose-volume constraints for 3D-CRT and IMRT planning for extremity sarcomas was devised. 4/5f IMRT with SIB resulted in better target coverage and significantly decreased OAR dose. Further evaluation of this technique within a clinical trial is recommended to demonstrate that the technical benefit of the more complex technique translates into patient-derived benefit by reducing late toxicity.
在治疗肢体软组织肉瘤(STS)时,传统放疗的剂量可能超过正常组织的耐受量。本研究通过比较三维适形放疗(3D-CRT)和调强放疗(IMRT),旨在优化靶区覆盖范围并降低危及器官(OAR)的积分剂量。
对 10 例接受肢体 STS 术后放疗的患者进行评估。PTV(1)定义为肿瘤床加 5cm 上下和 3cm 周向,PTV(2)定义为 2cm 各向同性。OAR 定义为整个股骨、血管神经束、组织通道和 PTV(1)外的正常组织。对于每位患者,比较了两阶段 3D-CRT 与 2/3 野(2/3f)和 4/5 野(4/5f)调强放疗同步整合增敏(SIB)。主要的计划目标是尽量降低股骨和皮肤通道的剂量。使用容积分析、适形度和不均匀性指数进行计划比较。
定义了包含靶区和 OAR 的剂量/体积限制的计划方案。4/5f IMRT 显示出最大的适形度和均匀性。与 3D-CRT 相比,2/3f(p=0.01)和 4/5f(p=0.0009)的 IMRT 可显著降低股骨 V45。4/5f IMRT 可显著降低正常组织 V55(p=0.004)和最大剂量(p=0.04),与 3D-CRT 相比。
制定了一套可重复的 3D-CRT 和 IMRT 计划指南和剂量-体积限制。4/5f IMRT 联合 SIB 可更好地覆盖靶区,同时显著降低 OAR 剂量。建议在临床试验中进一步评估该技术,以证明更复杂技术的技术优势转化为患者受益,从而降低晚期毒性。